Trial Profile
Effects of Lactoferrin on Chronic Inflammation in the Elderly
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Oct 2023
Price :
$35
*
At a glance
- Drugs Recombinant lactoferrin (Primary)
- Indications Inflammation
- Focus Therapeutic Use
- Acronyms ELCIE
- 16 Apr 2019 Status changed from recruiting to completed.
- 16 Aug 2017 Status changed from not yet recruiting to recruiting.
- 24 Nov 2016 New trial record